SARS-CoV-2-IN-14
SARS-CoV-2-IN-14 is an orally bioavailable niclosamide analogue with potent antiviral activity against SARS-CoV-2 (IC50 0.39 μM) . It demonstrates improved metabolic stability in human plasma and liver S9 fractions compared to niclosamide, leading to enhanced pharmacokinetic profiles in vivo for antiviral research.
Product Specifications
CAS Number
22203-98-1
Product Name Alternative
3',5-Dichlorosalicylanilide, SARSCoV, SARS-CoV-2 3CL, SARS-CoV-2-IN-14
Field of Research
Infectious Disease & Virology
Purity
99.30% (May vary between batches)
Solubility
DMSO:9 mg/mL (31.9 mM)
Smiles
C (NC1=CC (Cl) =CC=C1) (=O) C2=C (O) C=CC (Cl) =C2
Molecular Formula
C13H9Cl2NO2
Molecular Weight
282.12
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6139035-01 0.1 mL
SH3BP5 (SH3 Domain-binding Protein 5, SH3BP-5, SH3 Domain-binding Protein that Preferentially Associates with BTK, SAB) APC
Sign In for Pricing
View Details MBS6139035-02 5x 0.1 mL
SH3BP5 (SH3 Domain-binding Protein 5, SH3BP-5, SH3 Domain-binding Protein that Preferentially Associates with BTK, SAB) APC
Sign In for Pricing
View Details 
